Viking Therapeutics Inc. (VKTX) price slipped close to $6.14 early on Friday: What’s Next?
Viking Therapeutics Inc. (NASDAQ:VKTX) has a beta of 1.82. The stock’s Relative Strength Index (RSI) is 58.42, with weekly volatility at 4.50% and ATR at
Viking Therapeutics Inc. (NASDAQ:VKTX) has a beta of 1.82. The stock’s Relative Strength Index (RSI) is 58.42, with weekly volatility at 4.50% and ATR at
Viking Therapeutics Inc. (NASDAQ:VKTX) previous close was $5.62 while the outstanding shares total 74.97M. The firm has a beta of 1.83. VKTX’s shares traded higher
Viking Therapeutics Inc. (NASDAQ:VKTX) Relative Strength Index (RSI) is 47.73, with weekly volatility at 3.81% and ATR at 0.26. The VKTX stock’s 52-week price range
Viking Therapeutics Inc. (NASDAQ:VKTX) shares fell to a low of $5.22 before closing at $5.24. Intraday shares traded counted 0.84 million, which was 15.18% higher
Viking Therapeutics Inc. (NASDAQ:VKTX) shares traded lower over the last trading session, losing -0.38% on 05/26/21. The shares fell to a low of $4.9508 before
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne